This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI - Whole Genome Sequencing-Sickle Cell Patient
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a combined synopsis/solicitation for commercial items under solicitation number 75N98026Q00368. This non-competitive Notice of Intent (NOI) seeks to award a firm-fixed-price purchase order to The Broad Institute, Inc. for whole genome sequencing (WGS) services specifically targeting sickle cell disease (SCD) patient samples. The contract is conducted in accordance with FAR Part 12.603 for streamlined solicitation of commercial services and is not expected to exceed the simplified acquisition threshold. The acquisition leverages statutory authorities allowing for a sole-source procurement without full and open competition, citing the Broad Institute's unique qualifications due to their prior sequencing of this patient cohort and their use of established pipelines compatible with existing datasets. The primary goal of this procurement is to obtain high-quality WGS data to support ongoing genomic research and predictive modeling efforts related to sickle cell disease. Utilizing the Broad Institute ensures consistency across datasets, avoids technical and programmatic risks that could arise from using alternate vendors, and eliminates the need for reprocessing or revalidation of previous sequencing outputs. The solicitation was posted on May 15, 2026, with a response deadline of May 29, 2026, and falls under NAICS code 541990. Points of contact for the procurement process are provided through NIH, located in Bethesda, MD.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
(ii) The solicitation number is (insert solicitation number) and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).
This acquisition is conducted under the authority of the FAR Part 12.603 Streamlined solicitation for commercial products or commercial services and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).
The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order without providing for full and open competition (Including brand-name) to The Broad Institute, Inc. 415 Main Street Cambridge, MA 02142 for whole genome sequencing services.
The purpose of this acquisition is to obtain high-quality whole genome sequencing (WGS) services for sickle cell disease (SCD) patient samples to support ongoing genomic research and predictive modeling efforts. The Broad Institute is uniquely positioned to perform this requirement due to its prior sequencing of this specific cohort and use of established sequencing and bioinformatics pipelines aligned with existing datasets. Use of another vendor would introduce data variability, require reprocessing or validation of prior datasets, and pose unacceptable technical and programmatic risk.